Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients’ quality of life. The company has two franchises – Pain Management and Chronic Care – that address some of today’s most important healthcare needs, including reducing the use of opioids while helping patients move from surgery to recovery.
Avanos sells its recognized brands and products in more than 90 countries and holds market leading positions in multiple categories across its portfolio.
Avanos operates 8 principal medical device production facilities with 4,500 employees worldwide – generating approximately $745 million in net revenue.
Headquartered in Alpharetta, Georgia, Avanos is traded on the New York Stock Exchange under the ticker symbol “AVNS”.
For more information, visit www.avanos.com.